Details of the Drug Reposition

General Information of This Drug (ID: DMF2JDG)

• Drug Name: Dromostanolone (DMF2JDG)
• Synonyms: Drostanolo; Drostanolon; Drostanolona; Drostanolone; Drostanolonum; Medrosteron; Medrotestron; Methalone; Metholone; Prometholone; Drostanolo [DCIT]; SKI 27719; Drolban (TN); Drostanolona [INN-Spanish]; Drostanolone [INN:BAN]; Drostanolonum [INN-Latin]; Dihydro-2alpha-methyltestosterone; Dihydro-2-alpha-methyltestosterone; Dihydro-2.alpha.-methyltestosterone; Androstan-3-one, 17-hydroxy-2-methyl-, (2alpha,5alpha,17beta)-(9CI); (2R,5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-2,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one; (2alpha,5alpha,17beta)-17-hydroxy-2-methylandrostan-3-one; 17 beta-hydroxy-2 alpha-methyl-5 alpha-androstan-3-one; 17-beta-Hydroxy-2-alpha-methyl-5-alpha-androstan-3-one; 17beta-Hydroxy-2alpha-methyl-5alpha-androstan-3-one; 2-alpha-Methyl-17-beta-hydroxy-5-alpha-androstan-3-one; 2-alpha-Methyldihydrotestosterone; 2.alpha.-Methyldihydrotestosterone; 2a-methylandrostan-17b-ol-3-one; 2alpha-Methyldihydrotestosterone
• Therapeutic Class: Anabolic Agents
• Drug Type: Small molecular drug

Information on Drug Reposition of This Drug

6 Approved Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Diamond-Blackfan anemia	DISI2SNW	N.A.	Approved	[1]
Aregenerative anemia	DISAMDMG	N.A.	Approved	[1]
Aplastic anemia	DISJRSC0	3A70	Approved	[1]
Corneal ulcer	DIS8YN8N	9A76	Approved	[1]
Rosacea	DIS02PWG	ED90.0	Approved	[1]
Corneal abrasion	DIS3SD7J	NA06.4	Approved	[1]

1 Withdrawn Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Allergic conjunctivitis	DISZ5ZJN	9A60.02	Withdrawn	[2]

2 Discontinued in Phase 3 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Iritis	DISSA7AC	N.A.	Discontinued in Phase 3	[3]
Anterior uveitis	DISQ7EAD	9A96	Discontinued in Phase 3	[4]

1 Discontinued in Phase 2 Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Breast neoplasm	DISNGJLM	N.A.	Discontinued in Phase 2	[5]

1 Investigative Indication(s)

Indication Name	Indication ID	ICD-11	Status	REF
Iridocyclitis	DISV6UP4	N.A.	Investigative	[1]

References

• [1] Dromostanolone FDA Label
• [2] AMG 102, Pemetrexed Disodium, and Cisplatin in Treating Patients With Malignant Pleural Mesothelioma
• [3] Comparison of Adjuvant Chemotherapy Regimens in Treating Stage II/III Rectal Cancer
• [4] ClinicalTrials.gov (NCT00425438) A Study of CellCept (Mycophenolate Mofetil) in Patients With Lupus Nephritis.
• [5] EMMA-1 (Erbitux for Multiple Myeloma)